𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Primary lymphoma of the heart. Prolonged survival with early systemic therapy in a patient

✍ Scribed by Sucha Nand; G. Martin Mullen; Vassyl A. Lonchyna; Rogelio Moncada

Publisher
John Wiley and Sons
Year
1991
Tongue
English
Weight
350 KB
Volume
68
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Prolonged survival and effective palliat
Prolonged survival and effective palliation in patients with squamous cell carcinoma of the esophagus following endoscopic laser therapy
✍ David A. Karlin; Robert S. Fisher; Benjamin Krevsky πŸ“‚ Article πŸ“… 1987 πŸ› John Wiley and Sons 🌐 English βš– 382 KB πŸ‘ 2 views

Endoscopic laser therapy provides effective symptomatic palliation for patients with squamous cell carcinoma of the esophagus. To investigate whether this treatment also prolongs survival, a retrospective case-control study was performed. Ten patients with squamous cell carcinoma of the esophagus, d

Therapy for non-Hodgkin lymphoma in chil
Therapy for non-Hodgkin lymphoma in children with primary immunodeficiency: Analysis of 19 patients from the BFM trials
✍ Seidemann, Kathrin; Tiemann, Markus; Henze, GοΏ½nter; Sauerbrey, Axel; MοΏ½ller, Sus πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 English βš– 93 KB πŸ‘ 2 views

Background. Non-Hodgkin lymphomas (NHL) represent an important complication of primary immunodeficiency (ID), posing new therapeutic challenges in this patient population. This study analyzes clinical data and therapy results of pediatric patients with primary ID and NHL in three consecutive NHL-BFM

Prolonged survival in a patient with dis
Prolonged survival in a patient with disseminated malignant teratoma in the presence of a persistently elevated serum alpha-fetoprotein level
✍ Clive Stewart Lawson; Janine Lucia Mansi; Eve Wiltshaw πŸ“‚ Article πŸ“… 1989 πŸ› John Wiley and Sons 🌐 English βš– 222 KB πŸ‘ 2 views

The authors report a patient with disseminated malignant teratoma who has survived for 3.5 years after discontinuation of treatment despite a persistent and nonprogressive elevation of his serum alpha-fetoprotein level. Potential sources of the marker in his case are discussed and the possibility of